Objective: A proportion of older individuals report subjective memory complaints (SMCs), which can predict the development of cognitive impairment and dementia. Previous studies based on secondary care suggest that SMC is also associated with other adverse health consequences, including falls, fractures and increased healthcare utilization. In this study, we aimed to establish whether similar findings are observed in the wider population. Methods: Prospective analysis of the Cohort for Skeletal Health in Bristol and Avon, a population-based cohort recruited from primary care, was carried out. Data were collected by self-completion questionnaire at baseline and 2 years. SMC was assessed at baseline. Fractures, measures of falls, mobility and healthcare utilization were assessed 2 years later. A random 5% subsample of data was validated against electronic general practitioner records. Logistic regression was used to identify independent associations, following adjustment for a range of confounders assessed at baseline. Results: Data were available on 3184 women. Three hundred and fifty participants (11.0%) reported SMC. They were older (73.3 ± 4.5 vs 72.0 ± 4.2 years) and less mobile compared with those not reporting SMC. SMCs at baseline were associated with an increased risk of upper limb fractures over the following 2 years (OR 1.72, 95% CI 1.02-2.90). SMCs were also associated with an increased risk of falls (OR 1.83, 95% CI 1.41-2.38) and increased healthcare utilization (OR for hospital appointments 2.20, 95% CI 1. 26-3.86). No association was observed with bone mineral density at any site. Conclusions: Subjective memory complaints are important markers of adverse health outcomes and should prompt interventions to reduce fractures such as physiotherapy-led fall reduction programmes.
Introduction
Cognition can be defined as the process of 'knowing' (Yasuhara et al., 2013) and reflects our ability to perceive, learn, concentrate and communicate. A change in cognition can affect an individual's socialization and self-care, including food preparation, taking medication and managing their finances (Wagster et al., 2012) . Cognitive impairment will also impact on how well an individual can cope with the effects of ageing such as illness or injury (Hendrie et al., 2006) . Symptoms of memory loss or subjective memory complaints (SMCs) can be one of the first signs of cognitive impairment (Guo et al., 2013) and are defined as everyday memory concerns expressed by an individual with or without objective evidence of memory deficit on neuropsychological testing (Abdulrab and Heun, 2008) .
The prevalence of SMC varies according to the population studied and method of capturing the SMC data. In one meta-analysis of 30 000 people (mean age 71.6 years) from around the world mainly identified through community-based surveys, SMC was reported in approximately 50% (Mitchell et al., 2014) . Other studies from primary healthcare (Jessen et al., 2014) and specialist clinics (Visser et al., 2009 ) have reported similar prevalences (41-52%). SMC increases with age: for example, there is a reported prevalence of 10% at 65 years of age (Jungwirth et al., 2004) increasing to 88% in those aged 85 years and older (Bassett and Folstein, 1993) . SMC is commonly associated with cognitive impairment. In one longitudinal cohort study of 2228 individuals (75 years and older) from primary care, those with SMC were more likely to be formally diagnosed with mild cognitive impairment (MCI) within 3 years compared with those without SMC (Luck et al., 2010) . Aside from potentially identifying those more likely to develop future cognitive decline (Gauthier et al., 2006) or dementia (Reisberg et al., 2010) , SMC has a positive correlation with depression (O'Connor et al., 1990) and anxiety (Jorm et al., 2001) .
In addition, an association has been reported between SMCs and frailty, poorer balance (Shin et al., 2011) , fractures (Lee et al., 2012) , reduced quality of life (Mol et al., 2007) and increased healthcare utilization (Waldorff et al., 2009) . However, the usefulness of these studies is limited by lack of control groups and difficulty extrapolating their findings to the general population because the majority were set in secondary care. It is essential that these relationships are examined further, particularly as there are effective interventions available to reduce the risks of falls (Choi and Hector, 2012) and fractures (Beard, 2012) and therefore decrease morbidity and improve quality of life.
An additional benefit to identifying individuals with SMC is that educational, lifestyle and medical interventions are most likely to be helpful when initiated at an early stage. Furthermore, a number of individuals with SMC may have a treatable cause for their symptoms detected such as infection, vitamin deficiency or depression (Small, 2001) . In recognition of this, the 2012 Dementia Commissioning for Quality and Innovation (CQUIN) has developed a new pathway aimed to improve the identification of patients with dementia and cognitive impairment by asking all inpatients aged 75 years and over (or their relatives), 'Have you/has the patient been more forgetful in the past 12 months to the extent that it has significantly affected your/their daily life' (Matussek et al., 2010) . However, this CQUIN only applies to the inpatient setting and does not identify people in primary care with subjective memory impairment.
The Cohort for Skeletal Health in Bristol and Avon was set up to trial a screening tool for osteoporotic vertebral fractures in 3200 women aged 65 to 80 years from primary care in the UK (Clark et al., 2012) . At baseline, all participants were asked about SMCs and were then followed up for 2 years. The objective of this study was to evaluate the prevalence and natural history of SMC in the primary care population of older women and identify whether SMCs are associated with future falls, fractures or healthcare utilization.
Methods

Study design
This study is a prospective analysis of a populationbased cohort of 3200 post-menopausal women with 2 years follow-up.
Study population
The Cohort for Skeletal Health in Bristol and Avon (COSHIBA) consists of 3200 postmenopausal women with a date of birth between 1 January 1927 and 31 December 1942. Full descriptions of the method of recruitment have been published previously (Clark et al., 2012) , but briefly, participants were recruited for a randomized controlled trial of a screening programme to identify women with osteoporotic vertebral fractures (ClinicalTrials.gov NCT00463905). There were no exclusion criteria, although some general practitioners (GPs) did not invite women they thought would be inappropriate through illness. Data for this study are from the self-completion questionnaires on entry to the study and over the 2 years of follow-up. As previously described (Clark et al., 2011) , a random 5% subsample was verified against electronic GP records, and in general, there was good agreement. Ethical approval was obtained from the Gloucestershire Research Ethics Committee (REC 07/Q2005/47).
Main exposure: self-reported memory complaint Data on SMC were collected by asking, 'Do you or have you suffered from memory problems in the last two years?'. The response was a binary yes/no, and the participants who did not answer were regarded as having missing data. The same question was repeated at the end of the 2-year follow-up. Our primary exposure was self-reported SMC at baseline. The participants were further classified as persistent SMC if they self-reported SMC at both baseline and 2 years or intermittent SMC if they self-reported SMC at baseline but not at 2 years.
Outcomes
All outcome data were collected via self-completion questionnaires during the 2 years of follow-up and after baseline SMC was recorded.
Fractures. Self-reported data were collected at 6-month intervals during the 2-year follow-up about any new fracture occurring since entry to the study. As previously described, the majority of fractures were upper limb fractures (Clark et al., 2011) . A random 5% subsample of reported fractures was verified against GP records, and 79.5% were confirmed, similar to that found by other researchers (Boissonnault, 2005) .
Falls. Self-reported data on falls experienced over the previous 2 years were collected at 2 years after baseline data collection. Falls were categorized into those who had one or more falls per year and those who had fewer. As previously reported (Clark et al., 2011) , a random 5% subsample of self-reported falls was verified against GP records, and 69.2% of those reporting falling more than once per year had no falls recorded on the computerized GP records, suggesting that these electronic records underestimate the true prevalence of falls.
Healthcare utilization. At 2 years of follow-up, the participants were asked how often they had appointments with practice nurses, GPs (face to face at surgery or for home visits), hospital out-patients or physiotherapists during the past year. Data on number of nights spent in hospital were also collected.
Potential confounders and other data
Age was calculated from date of birth. Medication use was identified by classifying whether participants had ever taken oral steroids for more than 3 months, hormone replacement therapy (HRT), osteoporosis treatment and use of anxiety pills or sleeping pills. Data were also collected on age, socioeconomic status (housing tenure categorized as owned/mortgaged, private rental/housing association or council housing) and highest achieved educational qualification (categorized into none/basic matriculation, vocational, O-levels or equivalent, A-levels or equivalent or university degrees). Data were also collected on current and previous smoking, current and previous heavy alcohol intake defined as more than one alcoholic drink per day.
Frailty. At baseline, the participants were asked how far they could walk (divided into more than 400 yards or 0 to 400 yards), and whether they used a walking aid regularly. Reduced mobility was used as a proxy for frailty, based on Fried's frailty criteria (Abizanda et al., 2013) .
Data were also collected at baseline on the number of fall experiences over the preceding 5 years. Body mass index data were also collected at baseline. In addition, data were collected on self-reported diagnosis of osteoporosis, although this was analysed separately and not as a confounder. Bone density was assessed in a subgroup by dual energy X-ray absorptiometry at the lumbar spine, right total hip and right femoral neck, as previously described (Clark et al., 2014) .
Statistical analysis
Statistical analysis was carried out using STATA vs13 software by UA. Simple descriptive statistics, including mean/standard deviation for age and proportions for categorical data, were calculated. Univariable associations between SMC and the outcomes were assessed using Chi-squared tests. Logistic regression analyses were used to calculate odds ratio (OR) and 95% confidence interval (CI) for outcomes according to presence or absence of SMC at baseline. Multivariable logistic regression was used to estimate associations between SMC and the outcomes after adjusting for baseline confounders. Data collected at baseline were used as confounders, chosen as a 'confounding set' through literature review and knowledge of SMC and fractures: the confounding set was age, baseline socioeconomic statuses and frailty. Standard methods for assessing confounding were used, that is, change in size of effect of more than 10%. Once associations between SMC and outcomes at 2 years were identified, a directed acyclic graph (DAG) was used to direct the further statistical analysis and to encode our assumptions (Greenland et al., 1999) . The roles of a priori DAGs are to (i) develop the statistical model: Figure 1 shows our assumed association between SMC and fractures; and (2) consider the robustness of the assumptions encoded within the DAG. The participants with missing data for specific items were excluded from the relevant analyses. Sensitivity analyses were performed using a different definition of SMC: self-reported SMC at both baseline and 2-year follow-up (persistent SMC) compared with no selfreported SMC at either baseline or follow-up. All fractures were used as one of the primary outcomes, followed by upper limb fractures only as a subanalysis: Upper limb fractures are the most common osteoporotic fracture of older women, whereas 'all fractures' will also include those occurring after high trauma.
Results
Full data were available on 3184 participants. Three hundred and fifty (11.0%) reported SMC at baseline (Figure 2 ). Of those with SMC at baseline, 145 (53.7%) still reported SMC 2 years later (persistent SMC), compared with 125 (46.3%) who no longer reported SMC at 2 years (intermittent SMC). At 2 years, 138 (5.5%) of those without SMC at baseline now selfreported SMC. 80 (22.9%) of those with SMC at baseline were lost to follow-up during the 2 years compared with 347 (12.2%) of those without SMC. Women who reported SMC at baseline and were lost to follow-up had lower socioeconomic status as reflected by housing tenure compared with women with SMC and follow-up date (67% owned or mortgaged their own home vs 82%, p = 0.006). Similarly, those women with SMC and lost to follow-up had reduced mobility (for example 46% could walk less than 400 yards vs 27% with full data collection, p = 0.031) and were more likely to smoke compared with those women with SMC and follow-up at 2 years (16 vs 7%, p = 0.015).
Those with SMC at baseline were slightly older and had lower socioeconomic status, as reflected by housing tenure (Table 1 ), but no association was seen with highest achieved educational qualification (results not shown). At baseline, those with SMC had poorer mobility, as reflected by walking time and use of a walking aid, were more likely to report previous heavy alcohol intake and were more likely to smoke (currently or given up). Those with SMC at baseline were more likely to have had HRT or medications for anxiety. No association was seen between SMC and baseline body mass index, use of steroids or current heavy alcohol intake. Considering all the data available on use of medications (steroids, osteoporosis treatments, HRT, anxiety pills and sleeping pills), 248 (70.9%) of those with SMC used at least one of these medications at baseline compared with 1495 (52.8%) of those without SMC at baseline (p < 0.001 for difference). Those with persistent SMC were more likely to have lower socioeconomic background at baseline compared with those with intermittent SMC (Table 2 ) and have more falls over the 2-year follow-up.
Self-reported SMC at baseline was associated with upper limb fractures and increased falls 2 years later (Table 3 Model A). For upper limb fractures, the size of association did not change after adjusting for baseline confounders and frailty (Table 3 Models B and C). Similarly, adjustment for baseline confounders and frailty did not change the association between SMC and falls at 2 years (Table 3 Models B and C). Sensitivity analyses performed using persistent SMC compared with those who did not report SMC at baseline or follow-up did not change direction of association or size of effect, but due to smaller numbers, had wider confidence intervals.
To further explore the association between SMC and fractures (Figure 1) , we adjusted the association between SMC and fractures for falls. Adjustment for falls at 2 years attenuated the association between our variables. The association between SMC at baseline and fractures over the following 2 years is mainly explained by falls over the 2 years. Sensitivity analyses performed using persistent SMC compared with those who did not report SMC at baseline or follow-up did not change pSMC, persistent subjective memory complaint; iSMC, intermittent subjective memory complaint; BMI, body mass index; GP, general practitioner; HA, housing association; NH, nursing home. SMCs, subjective memory complaints; OR, odds ratio; CI, confidence interval; GP, general practitioner. The results shown are mean and SD, with (A) unadjusted ORs, (B) ORs adjusted for baseline confounders, (C) additionally adjusted for baseline frailty variables, (D1) additionally adjusted for falls at 2-year follow-up and (D2) adjusted for potential confounders, baseline frailty and all types of fracture at 2 years. Specific variables in the models are for (B) age, housing tenure, medication use, current and previous heavy alcohol intake and smoking; for (C) B + baseline falls, baseline mobility and baseline using walking aids; for (D1) C + falls at 2 years; and for (D2) C + all types of fractures at 2 years.
direction of association or size of effect, but due to smaller numbers, had wider confidence intervals. Bone density data from dual-energy X-ray absorptiometry were available on 258 participants at the lumbar spine and 235 at the right hip (total neck and femoral neck). No association was seen between SMC at baseline and this objective measure of bone density. An association was seen between SMC at baseline and self-reported diagnosis of osteoporosis at follow-up (OR for self-reported osteoporosis 1.84, 95% CI 1.31 to 2.60, p < 0.001). Additionally, adjusting the association between SMC and upper limb fractures for a self-reported diagnosis of osteoporosis slightly attenuated the size of effect: OR for upper limb fractures in those with SMC at baseline, adjusted for baseline confounders and frailty and a diagnosis of osteoporosis 1.61, 95% CI 0.89 to 2.91, p = 0.112.
Self-reported SMC at baseline was associated with increased healthcare utilization over the following 2 years (Table 3) . After adjustment for baseline confounders and frailty, only the association between SMC and consultant hospital appointments remained (OR 2.30, 95% CI 1.25 to 4.23). Additional adjustment for fractures did not change the association between SMC and consultant appointments in hospital (OR for consultant hospital appointments 2.30, 95% CI 1.25 to 4.24, p = 0.007).
Discussion
We demonstrate for the first time that self-reported memory complaints within the primary care population of older women are associated with an increased risk of fractures, falls and consultant appointments in hospital over the following 2 years. The association between SMC and fractures was mainly explained through increased falls. This highlights that SMCs are an important marker of adverse health outcomes and should prompt a review of falls risk and general health, with a view to improving the health of the individual and reducing societal costs of healthcare. Targeting interventions to older women with SMCs has the potential to be a cost-effective way of identifying a high-risk group that would benefit from interventions such as physiotherapy-led fall-reduction programmes. However, at present, it is only people attending secondary care that are routinely asked about SMCs in the UK, and our results suggest that this should be extended to the primary care population.
One objective of this study was to evaluate the prevalence and natural history of SMC in the primary care population. SMCs have been evaluated in a wide range of settings; however, comparatively, few studies have focused on patients within primary care (Archer et al., 2015) . In our study, the prevalence of SMC was 11%. This is similar to other studies that have reported rates of 10% (Jorm et al., 2004) and 23% (Waldorff et al., 2012) . Although memory complaints can be relatively common in primary care populations, these symptoms may not be volunteered by patients to their GP (Jorm et al., 2004 , Waldorff et al., 2012 ; however, those with SMC have (as in our study) been found to present more frequently to their GP (Jorm et al., 2004) . We found that those with SMC at baseline had a 60-100% increase in healthcare utilization over the following 2 years compared with those without SMC. This concurs with other populationbased studies that have shown similar utilization, pointing to increased nursing home placement over a 3-year period (19). Our results show that SMC is independently associated with consultant appointments in secondary care over a 2-year period, and this has important economic consequences and suggest that SMC is a key indicator for targeting healthcare in an efficient manner.
Interestingly, only half of our cohort with SMC at baseline continued to report these symptoms at follow-up. This finding mirrors the fluctuation in cognitive performance seen in populations of individuals with MCI, where there are symptoms of memory complaints and measurable cognitive impairment (Sachdev et al., 2013) . In our population, symptoms may have resolved where they were related to a mood disorder or treated reversible cause. Alternatively, this change in perception may represent diminishing insight into cognitive problems, where the cognitive impairment is progressing.
Our finding that self-reported SMC at baseline is associated with increased falls over the following 2 years in older women from primary care has not to our knowledge been previously reported. Crosssectional studies based on older people recruited from hospital outpatient clinics (Stijntjes et al., 2015) or the community (Mignardot et al., 2014) have shown an association between MCI and reduced standing balance or increased postural sway. Our results add to this literature and suggest that this association between SMC and poor balance may result in increased falls and injuries. This is important, as there are a wide range of interventions available for balance retraining in community-dwelling older adults (Mulligan et al., 2014) , and it has been suggested that these exercisebased interventions may also work in the older population with MCI (Jeon et al., 2014) , with the potential to reduce falls and fractures.
Because the relationship between SMC and fractures was largely attenuated by adjusting for falls, which were also increased, our results suggest that the relationship between SMC and future fractures is most likely be due to falls. Conceivably, there may also be a pathway via bone fragility. Our study identified an association between SMC and self-reported diagnosis of osteoporosis, but not with objective measures of low bone mass in a subset. The literature is limited, but it has been suggested that there may be an association between SMC, lower bone mass and early Alzheimer's disease (Lee et al., 2012) and between osteoporosis and a decline in cognition and function over the following 5 years (Stijntjes et al., 2015) . However, these studies often have small numbers and may be underpowered to show a relationship between cognitive impairment and fractures.
Our results have implications for health policy and targeting interventions to high-risk groups, with an aim of reducing falls and fractures and thereby reducing societal healthcare costs. Our results suggest that SMC within the community population of older women should be a 'red flag' and should highlight someone at a high risk of reduced mobility, increased falls and increased healthcare utilization to allow initiation of interventions to reduce falls and fractures. Currently, there is no country-wide scheme to identify older women with SMC in the community, and the UK-based CQUIN pathway to identify women with SMC in secondary care has been contentious because of no universally agreed 'objective assessment' of women who self-report SMC. Our results suggest that an important component of this assessment should be fall and fracture risk assessment, for which there are already developed pathways. In addition, consideration needs to be given to 'screening' for SMC within the community.
There are limitations to this study. As previously described, the recruited study cohort only included 38.9% of eligible women (Clark et al., 2012) . In addition, those women with SMC who were lost to follow-up were different to the women with SMC who stayed in the study. This likely bias may have implications for the generalizability of our results. However, it is most likely that the women who were not recruited to our study have a higher prevalence of SMC than the women who did take part, and therefore, our results will not represent an overestimate of either the prevalence of SMC or the association with reduced mobility, fractures and healthcare utilization. Another limitation is that data were not specifically collected on depression. However, all adjusted models included adjustment for use of medications, including anxiety and sleeping pills. A further limitation is the use of self-reported fracture data. However, in the 5% random subsample compared against electronic GP records, the fracture and fall data do not suffer from any non-random misclassification (Clark et al., 2011 ), but we were unable to verify healthcare utilization data. A final important limitation is the use of self-reported data from people who also selfreport SMC. However, it is likely that any recall bias (including under-reporting and over-reporting) associated with SMC will result in random misclassification, and this is most likely to bias our results towards the null rather than create spurious associations.
In conclusion, we present the first prospective data showing an association between self-reported SMC and an increase in falls, fractures and healthcare utilization over the following 2 years. This has important implications for policy development and suggests that SMC within the community population of older women should be a 'red flag' and should lead to further assessment and interventions. This is likely to be a cost-effective way of targeting healthcare to the older population, with an aim of improving individual's health-related quality of life and reducing societal costs in the longer term.
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